E. Hanover, New Jersey 07936

  • Osteopenia


Osteoporosis prevention is important in patients with osteopenia (low bone density). This study will test the safety and efficacy of zoledronic acid in patients diagnosed with osteopenia.


Inclusion Criteria: - Postmenopausal - Greater than or equal to 45 years of age - Osteopenia (lumbar spine bone mineral density [BMD] T-score between -1.0 and -2.5, and BMD T-score > -2.5 at the femoral neck) Exclusion Criteria: - Patients with more than one Grade 1 vertebral fracture (as per Genant method; patients with one Grade 1 vertebral fracture are eligible to participate) - Patients with any Grade 2 or 3 vertebral fracture (as per Genant method) - Patients with 25-(OH) vitamin D levels less than 15 ng/mL prior to randomization Other protocol-defined inclusion/exclusion criteria may apply.



Primary Contact:


Backup Contact:


Location Contact:

E. Hanover, New Jersey 07936
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: April 07, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.